LTS Lohmann Therapie-Systeme AG: LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business

ANDERNACH, Germany, June 8, 2023 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery

Related Keywords

United States ,Andernach ,Rheinland Pfalz ,Germany ,China ,Shanghai ,Zeiten ,Mecklenburg Vorpommern ,Israel ,Stefan Klotter ,Andrei Yosef ,Van Buijtenen ,Iris Schnitzler ,Eitan Medical Ltd ,Transdermal Patches ,Oral Thin Films ,Micro Array Patches ,General Manager ,Device Technologies ,West Caldwell ,Stabile Ertr ,Chart Profi Stefan Klotter ,Blue Chips ,Lohmann ,Therapie ,Systeme ,Ompletes ,Entry ,Barge ,Olecule ,Drug ,Delivery ,Cquisition ,Sorrel ,Wearable ,Injection ,Device ,Business ,